Literature DB >> 21161459

Evaluation of ionotropic cross-linked chitosan/gelatin B microspheres of tramadol hydrochloride.

Sanat Kumar Basu1, Kunchu Kavitha, Mani Rupeshkumar.   

Abstract

Microspheres of tramadol hydrochloride (TM) for oral delivery were prepared by complex coacervation method without the use of chemical cross-linking agents such as glutaraldehyde to avoid the toxic reactions and other undesirable effects of the chemical cross-linking agents. Alternatively, ionotropic gelation was employed by using sodium-tripolyphosphate as cross-linking agent. Chitosan and gelatin B were used as polymer and copolymer, respectively. All the prepared microspheres were subjected to various physicochemical studies, such as drug-polymer compatibility by thin layer chromatography (TLC) and Fourier transform infrared (FTIR) spectroscopy, surface morphology by scanning electron microscopy, frequency distribution, drug entrapment efficiency, in vitro drug release characteristics and release kinetics. The physical state of drug in the microspheres was determined by differential scanning calorimetry (DSC) and X-ray diffractometry (XRD). TLC and FTIR studies indicated no drug-polymer incompatibility. All the microspheres showed initial burst release followed by a fickian diffusion mechanism. DSC and XRD analysis indicated that the TM trapped in the microspheres existed in an amorphous or disordered-crystalline status in the polymer matrix. From the preliminary trials, it was observed that it may be possible to formulate TM microspheres by using biodegradable natural polymers such as chitosan and gelatin B to overcome the drawbacks of TM and to increase the patient compliance.
© 2010 American Association of Pharmaceutical Scientists

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161459      PMCID: PMC3066349          DOI: 10.1208/s12249-010-9537-2

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  20 in total

1.  Two-stage optimization process for formulation of chitosan microspheres.

Authors:  Rajesh R Dubey; Rajesh H Parikh
Journal:  AAPS PharmSciTech       Date:  2004-02-06       Impact factor: 3.246

2.  Determination of the physical state of drug in microcapsule and microsphere formulations.

Authors:  A K Dash
Journal:  J Microencapsul       Date:  1997 Jan-Feb       Impact factor: 3.142

3.  5-fluorouracil loaded chitosan microspheres for chemoembolization.

Authors:  E B Denkbaş; M Seyyal; E Pişkin
Journal:  J Microencapsul       Date:  1999 Nov-Dec       Impact factor: 3.142

4.  An evaluation of the efficacy and tolerability of oral tramadol hydrochloride tablets for the treatment of postsurgical pain in children.

Authors:  Julia C Finkel; John B Rose; Michael L Schmitz; Patrick K Birmingham; George A Ulma; Joel B Gunter; Avital Cnaan; Charles J Coté; Robert A Medve; Mark S Schreiner
Journal:  Anesth Analg       Date:  2002-06       Impact factor: 5.108

5.  An alternative method to the evaluation of similarity factor in dissolution testing.

Authors:  P Costa
Journal:  Int J Pharm       Date:  2001-06-04       Impact factor: 5.875

6.  Preparation and characterization of chitosan microparticles intended for controlled drug delivery.

Authors:  J A Ko; H J Park; S J Hwang; J B Park; J S Lee
Journal:  Int J Pharm       Date:  2002-12-05       Impact factor: 5.875

7.  Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation.

Authors:  X Z Shu; K J Zhu
Journal:  J Microencapsul       Date:  2001 Mar-Apr       Impact factor: 3.142

8.  Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release.

Authors:  X Z Shu; K J Zhu; W Song
Journal:  Int J Pharm       Date:  2001-01-05       Impact factor: 5.875

9.  Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration.

Authors:  Chelladurai Sankar; Brahmeshwar Mishra
Journal:  Acta Pharm       Date:  2003-06       Impact factor: 2.230

10.  Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.

Authors:  Pramod Kumar; Sanjay Singh; Brahmeshwar Mishra
Journal:  Acta Pharm       Date:  2009-03       Impact factor: 2.230

View more
  2 in total

1.  Prunus armeniaca Gum-Alginate Polymeric Microspheres to Enhance the Bioavailability of Tramadol Hydrochloride: Formulation and Evaluation.

Authors:  Shazia Noureen; Sobia Noreen; Shazia Akram Ghumman; Fozia Batool; Huma Hameed; Sara Hasan; Fozia Noreen; Mervat A Elsherif; Syed Nasir Abbas Bukhari
Journal:  Pharmaceutics       Date:  2022-04-22       Impact factor: 6.525

2.  Simultaneous Optimization of Multiple Response Variables for the Gelatin-chitosan Microcapsules Containing Angelica Essential Oil.

Authors:  Qiang Li; Li-Jian Sun; Xian-Feng Gong; Yang Wang; Xue-Ling Zhao
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.